Lv5
954 积分 2021-07-04 加入
Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management
11天前
已完结
Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes
11天前
已完结
Toxic epidermal necrolysis: does immunoglobulin make a difference?
11天前
已完结
Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients
11天前
已完结
High-dose intravenous immunoglobulin for severe drug reactions: efficacy in toxic epidermal necrolysis
11天前
已完结
Intravenous immunoglobulin in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis: a meta-analysis with meta-regression of observational studies
11天前
已完结
Current Perspectives on Severe Drug Eruption
11天前
已完结
Stevens-Johnson syndrome and toxic epidermal necrolysis-like eruptions in patients treated with immune checkpoint inhibitors: a systematic review
12天前
已完结
Impact of multiple medical interventions on mortality, length of hospital stay and reepithelialization time in Toxic Epidermal Necrolysis, Steven-Johnsons Syndrome, and TEN/SJS Overlap - Metanalysis and metaregression of observational studies
12天前
已完结
Evidence of a Therapeutic Window for TNF-α Inhibitor and Intravenous Immunoglobulin Benefits in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: A Multicenter 6-Year Retrospective Study
13天前
已完结
皖公网安备34019202002308
